P502: PHASE II STUDY ON VENETOCLAX PLUS DECITABINE FOR ELDERLY (≥60 <75YEARS) PATIENTS WITH NEWLY DIAGNOSED HIGH-INTERMEDIATE RISK AML ELEGIBLE FOR ALLO-SCT: MIDTERM UPDATE OF VEN-DEC GITMO STUDY
Main Authors: | Domenico Russo, Nicola Polverelli, Marika Vezzoli, Stella Santarone, Luca Castagna, Francesco Onida, Stefania Bramanti, Roberto Sorasio, Angelo Michele Carella, Attilio Olivieri, Calogero Vetro, Germana Beltrami, Antonio Curti, Massimo Stefano Luca Bernardi, Valentina Mancini, Pellegrino Musto, Elisabetta Terruzzi, Piero Galieni, Cristina Skert, Luisa Giaccone, Raffaella Cerretti, Erika Borlenghi, Mirko Farina, Alessandro Leoni, Simona Bernardi, Stefano Calza, Angela Gheorghiu, Michele Malagola, Massimo Martino, Fabio Ciceri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968916.48200.82 |
Similar Items
-
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study
by: Emilio Paolo Alessandrino, et al.
Published: (2010-03-01) -
Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups
by: Francesco Onida, et al.
Published: (2013-09-01) -
P1539: INFECTION-RELATED MORTALITY CLINICAL-BIOLOGICAL SCORING SYSTEM (IRM-SCORE) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A VALIDATION STUDY IN GITMO CENTRES
by: Daniela Clerici, et al.
Published: (2023-08-01) -
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
by: Michele Malagola, MD, et al.
Published: (2023-03-01) -
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial
by: Gianluca Cavallaro, et al.
Published: (2024-08-01)